1. Home
  2. TVTX vs NWN Comparison

TVTX vs NWN Comparison

Compare TVTX & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • NWN
  • Stock Information
  • Founded
  • TVTX 2008
  • NWN 1859
  • Country
  • TVTX United States
  • NWN United States
  • Employees
  • TVTX N/A
  • NWN N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • NWN Oil/Gas Transmission
  • Sector
  • TVTX Health Care
  • NWN Utilities
  • Exchange
  • TVTX Nasdaq
  • NWN Nasdaq
  • Market Cap
  • TVTX 1.7B
  • NWN 1.7B
  • IPO Year
  • TVTX N/A
  • NWN N/A
  • Fundamental
  • Price
  • TVTX $15.02
  • NWN $40.93
  • Analyst Decision
  • TVTX Strong Buy
  • NWN Strong Buy
  • Analyst Count
  • TVTX 14
  • NWN 3
  • Target Price
  • TVTX $33.31
  • NWN $44.67
  • AVG Volume (30 Days)
  • TVTX 1.9M
  • NWN 289.4K
  • Earning Date
  • TVTX 05-01-2025
  • NWN 05-06-2025
  • Dividend Yield
  • TVTX N/A
  • NWN 4.78%
  • EPS Growth
  • TVTX N/A
  • NWN 11.40
  • EPS
  • TVTX N/A
  • NWN 2.61
  • Revenue
  • TVTX $273,533,000.00
  • NWN $1,213,808,000.00
  • Revenue This Year
  • TVTX $74.41
  • NWN $18.65
  • Revenue Next Year
  • TVTX $48.90
  • NWN $8.41
  • P/E Ratio
  • TVTX N/A
  • NWN $15.73
  • Revenue Growth
  • TVTX 75.65
  • NWN 3.88
  • 52 Week Low
  • TVTX $6.79
  • NWN $34.82
  • 52 Week High
  • TVTX $25.29
  • NWN $44.38
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 35.45
  • NWN 43.75
  • Support Level
  • TVTX $16.37
  • NWN $40.66
  • Resistance Level
  • TVTX $15.48
  • NWN $41.52
  • Average True Range (ATR)
  • TVTX 1.00
  • NWN 0.82
  • MACD
  • TVTX -0.51
  • NWN -0.06
  • Stochastic Oscillator
  • TVTX 3.83
  • NWN 48.80

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: